5-(2-Fluorophenyl)-1-[(Pyridin-3-Yl)Sulfonyl]-1H-Pyrrole-3-Carboxaldehyde

In kilogram-scale campaigns serving early-phase medicinal chemistry programs, 5-(2-fluorophenyl)-1-[(pyridin-3-yl)sulfonyl]-1H-pyrrole-3-carboxaldehyde is typically supplied as an off-white to pale-yellow crystalline powder with a purity specification of ≥ 98.5% (HPLC, 254 nm) and single maximum impurity capped at ≤ 0.5%. Residual solvents are controlled per USP <467> Option 1, with dimethylformamide and dichloromethane as the primary targets when the compound exits a pilot-scale Vilsmeier-Haack formylation sequence. Logistics documentation routinely includes a certificate of analysis referencing USP <621> for chromatographic purity and USP <731> for loss on drying (≤ 0.3% at 60 °C in vacuo). The aldehyde function dominates initial synthetic planning: it undergoes condensation with primary amines, hydrazines, and hydroxylamines at ambient temperature in anhydrous tetrahydrofuran or ethanol, with typical molar ratios of nucleophile to aldehyde maintained between 1.00:1.00 and 1.05:1.00 to minimize bis-imine byproducts. Plant engineers familiar with this intermediate flag that exotherms during Schiff-base formation can exceed 15 K on a 200 L glass-lined reactor unless the amine is added portionwise over 45–60 min with jacket cooling set to −5 °C. Downstream, the resulting imine is frequently reduced with sodium triacetoxyborohydride—charged at 1.3–1.5 equivalents relative to aldehyde—in dichloromethane at 0–5 °C, quenched into aqueous sodium bicarbonate, and extracted. The N-pyridylsulfonyl group remains intact under these conditions, but process development reports caution against pH excursions above 10 during workup, which accelerate sulfonamide cleavage and generate 5-(2-fluorophenyl)-1H-pyrrole-3-carboxaldehyde as a purity-critical degradant. The amine adducts populate diversity-oriented libraries aimed at kinome targets: reductive amination with substituted benzylamines, for instance, furnishes secondary amines that are further elaborated to pyridylsulfonyl-pyrrole-based ATP-competitive inhibitors. In a representative kilogram delivery, 4.8 kg of the aldehyde was transformed into a focused set of 72 amide and sulfonamide analogs, with final compound purity exceeding 97% by UPLC-QDa after automated flash chromatography on 330 g silica cartridges. The final pharmaceutical intermediates are not intended for human administration; they are handled under ICH Q7 guidance for GMP starting materials only when the sponsor designates the compound as a regulatory starting material post-proof-of-concept.

How Pre-Formation of the Hydrazone Impacts Purity Profiles in Agrochemical Lead Synthesis

Screening teams developing protoporphyrinogen oxidase (PPO) inhibitors and acetolactate synthase (ALS) disruptors value the pyridin-3-ylsulfonyl motif for its hydrogen-bonding footprint in the target enzyme’s sulfonylurea-binding pocket. The aldehyde is converted to the corresponding hydrazone by dropwise addition of 1.02 eq of methyl hydrazinecarboxylate to a methanol slurry of the substrate at 10–15 °C. When the addition is reversed—aldehyde added to hydrazine—local overdosage generates bis-hydrazone as a brick-red precipitate that occludes in-line filter housings downstream of the 100 L Hastelloy C-22 reactor commonly deployed in agrochemical pilot plants. The desired hydrazone crystallizes directly from the reaction mass with a polymorphic purity confirmed by DSC; endothermic onset must fall within 152–154 °C to meet the structural identity specification for subsequent heterocycle formation. Cyclocondensation with α-haloketones or α-bromoesters, performed in acetonitrile with triethylamine as base, builds 1,3,4-thiadiazine or pyrazoline rings that serve as propesticide scaffolds. A typical batch record specifies 0.95 eq of phenacyl bromide relative to hydrazone, a hold time of 6 h at 50 °C, and in-process control by TLC (silica, ethyl acetate/hexane 1:1). The cyclized product precipitates upon cooling and is isolated by centrifugation at 1500 RPM in a bottom-discharge basket centrifuge. Residual aldehyde in the hydrazone—measured as the 2,4-dinitrophenylhydrazine derivative by UV absorbance at 360 nm—must remain below 0.15 area% because it cross-reacts during the subsequent cyclization and yields an intractable dimer. For global registration, residues analyses under the OECD 106 adsorption/desorption guideline and CIPAC MT 30.2 for wet-sieving are applied to the technical-grade active ingredient produced from this pathway. The final herbicide candidate, typically tested as an emulsifiable concentrate containing 100 g a.i./L, has demonstrated leaf-bleaching activity at application rates below 50 g a.i./ha in glasshouse screenings for grass and broadleaf weed control in rice. Tox-1 batch processing demands dedicated equipment or validated cleaning protocols because the sulfonamide-pyrrole core shows Ames test liability at concentrations exceeding 5000 µg/plate in TA98 with S9 activation; this mutagenic potential, however, is eliminated through structural modification of the pyridine nitrogen oxidation state in the final active substance.

Polymer-sustained drug-eluting coatings on cardiovascular stents call for matrix monomers that combine hydrolytic stability with a thermally latent crosslinking site. The formyl substituent on the pyrrole core permits acid-catalyzed acetalization with poly(vinyl alcohol) (PVA, Mw ~31 000–50 000, 98–99% hydrolyzed) under conditions that do not attack the sulfonamide bridge. A typical compounding protocol suspends 1 wt% of the aldehyde monomer relative to PVA in deionized water adjusted to pH 2.5 with methanesulfonic acid. The slurry is heated to 85 °C with overhead stirring at 400 RPM in a jacketed glass reactor. As the PVA dissolves completely, the aldehyde partitions into the polymer-rich phase and forms cyclic acetal linkages with the 1,3-diol units of PVA, yielding a photocastable hydrogel with a gel fraction exceeding 92% after a 24 h Soxhlet extraction in water. Rheological characterization on a TA Instruments Discovery HR-30 controlled-stress rheometer with a 40 mm parallel-plate geometry reveals that storage modulus G′ increases from 320 Pa to 1840 Pa as the aldehyde molar ratio is raised from 0.5 mol% to 2.0 mol% (frequency 1 Hz, strain 0.5%, 37 °C). The crosslinked network remains dimensionally stable after ethylene oxide sterilization (EtO cycle: 4 h exposure at 55 °C, 70% RH), whereas control PVA films dissolve within 15 min in phosphate-buffered saline at 37 °C. Sirolimus can be co-loaded at 0.2 wt% without compromising the acetal crosslink density, as evidenced by an unchanged gel content measured according to ASTM D2765-16 Method A. The device-grade coating is deposited onto cobalt-chromium L-605 stents by an ultrasonic spray system (Sono-Tek ExactaCoat, nozzle frequency 120 kHz, flow rate 0.3 mL/min) and cured at 60 °C for 12 h under nitrogen. Manufacturing deviation reports from a cleanroom ISO Class 7 environment note that ambient relative humidity above 60% during spraying causes premature gelation in the nozzle tip, requiring daily rebuilds of the ultrasonic horn. The pyridylsulfonyl group provides sufficient radiocontrast for micro-CT evaluation of coating integrity pre-expansion, a practical advantage documented during regulatory submission for CE marking under Medical Devices Regulation 2017/745.

When Anhydrous Grignard Additions to the Formyl Group Encounter Solvent-Driven Selectivity Switches

Process chemistry groups accessing chiral diarylmethanols for orexin receptor antagonist back-ups treat the aldehyde with 2-fluorophenylmagnesium bromide in tetrahydrofuran at between −20 °C and −10 °C. Stoichiometry must be tightly held at 1.05 eq of Grignard reagent; at 1.20 eq competing deprotonation at the pyrrole C-5 position generates a carbanion that attacks a second molecule of aldehyde, producing a benzoin-type dimer detected at m/z 551.2 by LC-MS. The addition is quenched with saturated ammonium chloride—not aqueous acid—to preserve the sulfonamide bridge, which undergoes measurable solvolysis (>2% in 30 min) if the quench pH falls below 4.0. Phase separation studies using a Mettler Toledo EasyMax calorimeter demonstrate that adiabatic temperature rise can reach 22 K in volumes larger than 5 L, enforcing a semi-batch protocol with Grignard dosing over 90 min while jacket temperature is held at −25 °C. The resulting secondary alcohol is crystallized from methyl tert-butyl ether/heptane (1:3) to an enantiomeric excess of >98% after resolution with (S)-mandelic acid; the mother liquor is recycled through a racemization step catalyzed by aluminum isopropoxide in refluxing toluene. Physical characterization of the product alcohol includes a differential scanning calorimetry melting endotherm onset of 161–163 °C and specific optical rotation [α]_D²⁰ = +34.8° (c 1.0, methanol). The single-crystal X-ray structure (deposited as CCDC reference) confirms that the pyridylsulfonyl group adopts an orthogonal orientation relative to the pyrrole ring, a conformational lock that proves critical for binding to the OX₂ receptor site as assessed in FLIPR calcium flux assays with CHO-K1 stable transfectants. For API supply, a chromatography-free isolation was designed: after workup, the ethereal layer is dried over molecular sieves (3 Å, bead form), filtered through a 0.45 µm PTFE membrane, and concentrated to 3 vol under vacuum (50 mbar, 35 °C). Batches that fail the optical purity specification (≤ 97.5%) are reprocessable but must not be blended with prime material without full re-certification per ICH Q7 section 14.6. Trace fluoride ion from manufacturing degradation is controlled by ion chromatography to ≤ 15 ppm because residual fluoride interferes with the palladium-catalyzed coupling that installs the final heteroaryl appendage in the drug substance.

Spirocyclic Pyrrolidine Assembly via 1,3-Dipolar Cycloaddition: Regioselectivity Under Microwave Dielectric Heating

Synthesis of spiro[indoline-3,3′-pyrrolidine] cores for MDM2-p53 protein-protein interaction disruptors uses the aldehyde as a dipolarophile precursor. The aldehyde is condensed with sarcosine in ethanol at 78 °C to form the azomethine ylide in situ, which then undergoes [3+2] cycloaddition with an (E)-3-arylideneindolin-2-one dipolarophile. Conventional heating in an oil bath at 78 °C for 48 h affords the spiro adduct in 53–58% isolated yield with a diastereomeric ratio of 4.2:1. Transferring the same reaction to a Biotage Initiator+ microwave reactor (sealed 0.5–2.0 mL vial, absorption level set to very high) with a target temperature of 120 °C and hold time of 20 min raises the yield to 82% and reduces the cis/trans ratio to 8.7:1 by favouring the thermodynamically controlled exo-transition state. The pyridylsulfonyl group is rotationally restricted on the NMR timescale at ambient temperature; coalescence of the pyrrole C4 and C5 protons is observed at 338 K in DMSO-d6, providing a convenient internal thermometer for evaluating whether the cycloaddition exotherm has driven local temperatures above this marker. Post-reaction purification is accomplished on a Biotage Isolera One system with a SNAP Ultra 25 g column and a hexane/ethyl acetate gradient, cutting fractions by UV at 254 nm. Spirocyclic products are recrystallized from acetonitrile to afford a single diastereomer as white needles; HPLC purity acceptance criterion for biological testing is ≥ 99.0% (area). This scaffold has progressed to a cellular proliferation assay in SJSA-1 osteosarcoma cells, where a 5.0 µM dose restored p53 transcriptional activity to 64% of doxorubicin-positive control levels. The manufacturing permit for this advanced intermediate requires declaration of the synthetic procedure to national authorities under the Chemical Weapons Convention Schedule 1 exemption article when export volume exceeds 100 kg per annum purely because the N-pyridinesulfonyl moiety is a structural alert in the automated screening tools used by export control agencies—despite the compound having no contact activity against acetylcholinesterase.

Electrochromic windows and anti-glare rearview mirrors manufactured via vacuum sublimation demand monomeric charge-transfer chromophores with a sublimation temperature below 200 °C at 10⁻⁶ mbar and a residue-on-evaporation of <0.05%. 5-(2-Fluorophenyl)-1-[(pyridin-3-yl)sulfonyl]-1H-pyrrole-3-carboxaldehyde can be condensed with rhodanine-N-acetic acid in acetic anhydride at 110 °C to generate a merocyanine-type dye whose absorption maximum shifts from 442 nm (monomer in acetonitrile) to 508 nm when embedded in a poly(methyl methacrylate) solid matrix at 2.0 wt% loading. Multiple-gradient sublimation in a Creaphys SUBLIM-500 unit with a 4-zone oven profile (Zone 1: 140 °C, Zone 2: 165 °C, Zone 3: 185 °C, Zone 4: 120 °C) at a vacuum of 2×10⁻⁶ mbar yields a film with an RMS roughness of 0.35 nm by AFM over a 10 µm × 10 µm scan area. Device stacks deposited on indium tin oxide (ITO) coated glass with sheet resistance ≤ 10 Ω/sq exhibit a coloration efficiency of 424 cm²/C and a switching time (τ_c) of 1.2 s for a 90% optical contrast change at 580 nm when driven by a 1.8 V pulse. The N-pyridylsulfonyl group facilitates electron injection into the π-deficient pyrrole ring, lowering the LUMO to −3.65 eV (as determined by cyclic voltammetry with ferrocene internal reference, scan rate 100 mV/s, 0.1 M TBAPF₆ in acetonitrile) and thus enabling stable anodic coloration. Quality control of sublimed material follows the procedures described in ASTM F2687-13 for particulate contamination in polymer films used in optoelectronic devices; failure mode analysis traced five of six rejected lots to condenser plate temperature excursions exceeding ±2 °C of setpoint, which induced fractionation of a high-melting side product—identified as a pyridine N-oxide formed by autoxidation during ambient storage when the aldehyde was exposed to fluorescent lighting for more than 48 h. Consequently, amber glass packaging with molecular-sieve sachets and a “use-by” of 6 months from date of packing under argon is specified on the certificate of conformance.